Sample* | Gender | Age (years) |
Survival (years) |
Tumor Size (cm) |
Tumor Weight (g) |
Tumor Stage | Tumor Grade |
---|---|---|---|---|---|---|---|
ACC 4 | F | 56.7 | 5.9 | NA | NA | Recurrence | NA |
ACC 5* | F | 23.3 | 3.0 | 19 | 1100 | 2 | 3 |
ACC 8* | F | 56.5 | 0.6 | 9 | 190 | 4 | 4 |
ACC 9* | M | 53.2 | 9.0 | 8 | 195 | 3 | 2 |
ACC 10* | M | 67.8 | 1.7 | 7.6 | 150 | 2 | 4 |
ACC 11* | F | 54.2 | 18 | 15 | 890 | 2 | 1 |
ACC 12* | M | 72.1 | 0.4 | 9.5 | 175 | 4 | 4 |
ACC 13* | M | 46.9 | 0.1 | 12 | 235 | 4 | 4 |
ACC 17* | F | 26.7 | 16.6 | 3 | NA | Recurrence | 4 |
ACC 19* | M | 48.5 | 3.1 | 9 | 195 | 2 | 3 |
ACC 21* | F | 36.9 | 13.8 | 6.5 | NA | Recurrence | 4 |
ACC 22* | F | 67.3 | 6.4 | 10 | 230 | 2 | 2 |
ACC 23* | F | 27.7 | 9.8 | 8 | 149 | 2 | 2 |
ACC 26* | F | NA | NA | NA | NA | 2 | 3 |
ACC 27* | M | NA | NA | NA | NA | Recurrence | 2 |
ACC 28* | F | 58 | NA | 9 | 153.8 | 1 | 2 |
MPI1 | M | 42.0 | 14+ | NA | NA | Recurrence | NA |
MPI2 | F | 46.0 | NA | NA | NA | NA | NA |
MPI3* | F | 37.0 | NA | NA | NA | 3 | 2 |
ACC 30 | F | 20 | NA | 18 | NA | NA | 1 |
ACC 31 | F | 68 | 1.583 | NA | NA | Recurrence | 2 |
ACC 32 | F | 45 | NA | NA | NA | Recurrence | NA |
ACC 35 | M | 46 | NA | 16.0 | 1463 | 4 | NA |
ACC 45 | F | 32 | NA | 11 | 106 | 2 | 1 |
ACC 47 | M | 43 | NA | 4 | 60 | Recurrence | 1 |
ACC 48 | F | 45 | NA | NA | NA | 4 | NA |
ACC 51 | M | 40 | NA | 12 | 480 | NA | 2 |
ACC 59 | M | 52 | NA | 19.0 | 2310 | NA | NA |
ACC 61 | F | 60 | NA | 8.8 | 392 | 3 | NA |
ACC 84 | F | 27 | NA | 9.5 | 300 | NA | 1 |
ACC 85 | M | 70 | NA | 9.0 | 272 | NA | 1 |
ACC 112 | F | 53 | NA | NA | NA | 4 | NA |
ACC 114 | F | NA | NA | NA | NA | Recurrence | NA |
ACC 115 | F | 58 | NA | NA | NA | Recurrence | NA |
ACC 117 | M | 57 | 3+ | 4.0 | 39 | 1 | 1 |
ACC 118 | M | 59 | 7.583 | 2.5 | NA | Recurrence | NA |
ACC 123 | F | 59 | NA | 10 | 22 | 4 | NA |
ACC 129 | F | 55 | 0.583 | 10.5 | 277 | 2 | 4 |
ACC 132 | F | 51 | 6+ | 14.5 | 325 | Recurrence | 2 |
ACC 134 | F | 53 | 2.083 | 14.5 | 1243 | Recurrence | NA |
ACC 136 | M | 69 | 2.83 | 7.8 | NA | Recurrence | NA |
ACC 140 | M | 63 | 2.08+ | 7.8 | 132 | 4 | 4 |
ACC 149 | F | 28 | NA | NA | NA | 4 | NA |
ACC 150 | NA | NA | NA | NA | NA | Liver Metastasis from ACC 149 |
NA |
Sample previously reported in Stephan, et al, 2008
Alive at last follow-up
NA - not available